
Texas, US and Oxford, UK, 11th September 2023: Orano Med SAS, “Orano Med”, a biotechnology company developing Lead-212 (212Pb) Targeted Alpha Therapy against cancer, and Orbit Discovery Ltd, “Orbit”, a leader in the discovery of therapeutic peptide hits, today announced that they have entered into a collaboration to discover specific Peptide Receptor Radionuclide Therapies against […]